Medindia
Medindia LOGIN REGISTER
Advertisement

ATS Medical to Participate at the 27th Annual J.P. Morgan Healthcare Conference

Friday, January 9, 2009 General News
Advertisement
MINNEAPOLIS, Jan. 8 ATS Medical, Inc.(Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgeryproducts, announced today that it will participate at the 27th Annual J.P.Morgan Healthcare Conference at the Westin St. Francis in San Francisco.Michael Dale, President and CEO of ATS Medical, will present at 1:30 p.m.Pacific Time on Thursday, January 15, 2009.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

Attendance at the conference is by invitation only. A live audio-onlywebcast of the presentation will be broadcast via the Internet. Thoseinterested in listening to the webcast may access it at ATS Medical's websiteat http://www.atsmedical.com. An archived replay of the presentation willalso be available approximately one hour following the live presentation athttp://www.atsmedical.com.
Advertisement

About ATS Medical

ATS Medical, Inc. is dedicated to 'Advancing The Standards' of cardiacsurgery through the development, manufacturing and marketing of innovativeproducts and services for the treatment of structural heart disease. ATSMedical serves the cardiac surgery community by focusing on two distinct butoperationally synergistic market segments: heart valve disease therapy andsurgical ablation of cardiac arrhythmias.

ATS was originally founded to develop the ATS Open Pivot(R) Heart Valve asa new mechanical heart valve standard of care. Today the Open Pivot heartvalve is the preferred mechanical heart valve in many markets around the worldand the fastest growing mechanical prosthesis in the market. Building on thislegacy and addressing the largest market segment in heart valve therapy, theATS 3f(R) brand encompasses an innovative tissue heart valve portfolio toaddress conventional open surgery requirements as well as the growing demandfor less invasive sutureless based procedures. The ATS 3f(R) portfolioincludes offerings at various stages including early product development,pivotal clinical trials, and market commercialization. Completing theportfolio in heart valve therapy is the ATS Simulus(R) annuloplasty productline. Simulus products assist the surgeon in repairing a patient's nativeheart valve as an alternative to replacement. Continuing ATS Medical's focuson serving the cardiac surgery community are the ATS CryoMaze(TM) products forsurgical cryoablation of cardiac arrhythmias. ATS CryoMaze(TM) products areused by surgeons to treat patients suffering from cardiac arrhythmias, thelargest and fastest growing form of structural heart disease in populationsover 60 years of age. The ATS Medical web site is http://www.atsmedical.com.

SOURCE ATS Medical, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close